Related Experiment Video
Updated: Dec 22, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Combinatorial Vancomycin and Piperacillin/Tazobactam Results in Elevated Vancomycin Trough Concentration and Acute
Yoshiro Sakai1,2, Ryoko Miwa1, Masahiro Mitsuoka3
1Department of Pharmacy, Kurume University Hospital.
Abstract:
In the hospital, antibiotics are widely used to treat infections. We report a case of acute kidney injury (AKI) caused by an antibiotic drug combination. A 30-year-old Japanese male presented with lung metastases, pneumothorax, empyema, and methicillin-resistant Staphylococcus aureus (MRSA) infection. The patient received a combination of vancomycin and piperacillin/tazobactam, which resulted in elevated vancomycin trough concentration and subsequently in AKI. Renal function was restored upon vancomycin and piperacillin/tazobactam cessation. Though this patient had AKI most likely due to the combined use of two agents as has been reported in many cases, vancomycin trough concentration showed an unexpected abnormal increase when halting vancomycin treatment. This is the first report indicating a drug-drug interaction between vancomycin and piperacillin/tazobactam with unexpected abnormal vancomycin trough concentration, leading to AKI, additionally we think that there was a situation that he stressed against the kidney by a history of medications caused renal dysfunction and co-administration. We suggest that when using vancomycin in combination with piperacillin/tazobactam, the trough concentration of vancomycin must be confirmed simultaneously with renal function and evaluation, and that the combination of these two drugs should be minimized.
Insights
This case study highlights antibiotic-induced acute kidney injury (AKI) in a patient treated with vancomycin and piperacillin/tazobactam. The combination led to elevated vancomycin levels and AKI, emphasizing careful monitoring.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Antibiotics are crucial for treating hospital-acquired infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Acute kidney injury (AKI) is a potential complication of antibiotic therapy.
Observation:
- A 30-year-old male with MRSA infection and complications received vancomycin and piperacillin/tazobactam.
- The patient developed AKI with elevated vancomycin trough concentrations.
- Renal function improved after discontinuing both antibiotics.
Findings:
- This case suggests a drug-drug interaction between vancomycin and piperacillin/tazobactam, leading to AKI.
- An unexpected increase in vancomycin levels occurred even after halting treatment.
- Concurrent renal stressors may have contributed to the observed nephrotoxicity.
Implications:
- Close monitoring of vancomycin trough concentrations and renal function is essential when co-administered with piperacillin/tazobactam.
- Minimizing the combined use of these antibiotics may prevent AKI.
- This interaction warrants further investigation in clinical practice.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Acute Pyelonephritis II: Diagnostic Studies and Management

